NiKang Therapeutics Appoints Y. Peter Li, Ph.D., as Chief Executive Officer and Board Director
November 04, 2019 06:00 ET
|
NiKang Therapeutics
WILMINGTON, Del., Nov. 04, 2019 (GLOBE NEWSWIRE) -- NiKang Therapeutics, an early stage biotech company focused on discovering and developing innovative small molecule oncology medicines to help...